anti-MTX1 full human IgG1-NTX1 immunotoxin (Oncomatryx)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-MTX1 full human IgG1-NTX1 immunotoxin (Oncomatryx)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasm MetastasisNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOncomatryx SL

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOncomatryx SL

Active IndicationsN/A

Inactive IndicationsNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A